Androgen deprivation therapy and depression in men with prostate cancer treated with definitive radiation therapy.
Read MoreMore data on ADT and osteoporosis
Osteoporosis and prostate cancer; a 24-month prospective observational study during androgen deprivation therapy.
Read MoreIs ‘time to biochemical failure’ predictive of survival?
Time interval to biochemical failure as a surrogate end point in locally advanced prostate cancer: Analysis of randomized trial NRG/RTOG 9202
Read MoreDoes ADT increase the risk of rheumatoid arthritis in prostate cancer patients?
Androgen deprivation therapy for prostate cancer and the risk of autoimmune diseases
Read MoreDoes ADT increase the risk of dementia?
Androgen deprivation therapy for prostate cancer and risk of dementia
Read MoreWhat’s the best exercise program for men on ADT?
A phase II randomized controlled trial of three exercise delivery methods in men with prostate cancer on androgen deprivation therapy
Read MoreDoes ADT raise or lower the risk of getting gout?
Influence of androgen deprivation therapy on serum urate levels in patients with prostate cancer: A retrospective observational study
Read MoreDoes ADT affect tumour detection with PSMA PET/CT scans?
Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancer
Read MoreWhat are the major long-term health risks associated with ADT?
Risks of Major Long-Term Side Effects Associated with Androgen-Deprivation Therapy in Men with Prostate Cancer
Read MoreDoes adding a statin make ADT more effective?
The impact of statins in combination with androgen deprivation therapy in patients with advanced prostate cancer: A large observational study.
Read More